On April 4, 2016, CMS released its 2017 Final Call Letter. CMS acknowledged AMCP in the 2017 Final Call Letter and credits the important work that AMCP’s Medication Therapy Management Advisory Group is doing to develop a framework to define drug therapy problems. Additionally, CMS altered its timeline for removing the high-risk medication (HRM) measure from the Star Ratings from 2017 to 2018.
AMCP summary of the CMS 2017 Draft Call Letter.
AMCP Summary: Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter
CY 2016 Medication Therapy Management Program Guidance and Submission Instructions
Draft report from AHRQ.
The Centers for Medicare and Medicaid Services (CMS), will allow for certain MTM activities and fraud reduction activities to count toward Medicare Part D and Medicare Advantage medical loss ratio (MLR)
On May 23, 2013, CMS finalized a rule that will allow for certain MTM activities and fraud reduction activities to count toward Medicare Part D and Medicare Advantage medical loss ratio (MLR).
Medication Therapy Management in Pharmacy Practice: Core Elements of an MTM Service Model Version 2.0 is an evolutionary document that focuses on the provision of MTM services in settings where patients or their caregivers can be actively involved in managing their medications. The original version 1.0 document described the foundational or core elements of MTM services that could be provided by pharmacists across the spectrum of community pharmacy.
